Long-Lasting Anti-emetic Effect of T-2328, a Novel NK_1 Antagonist
スポンサーリンク
概要
- 論文の詳細を見る
The effect of T-2328 {2-fluoro-4-methoxy-3-[[[(2S,3S)-2-phenyl-3-piperidinyl] amino]methyl]-[1,1-biphenyl]-4-carbonitrile dihydrochloride}, a novel tachykinin NK1–receptor antagonist, was examined on cisplatin-induced emesis in ferrets. Cisplatin induced acute emesis in 24 h and delayed emesis during 24 and 72 h, respectively. Ondansetron, a 5-HT3 antagonist, almost completely blocked the acute emesis and transiently reduced the delayed emesis. In contrast, T-2328 elicited long-lasting anti-emetic effects on both acute and delayed phases by a single intravenous administration. Suppression of delayed emesis was not due to elimination of the acute phase because the delayed emesis was also suppressed by administration after the onset of delayed emesis. Persistent blockade of NK1 receptors in the brain was demonstrated by inhibition of the NK1 agonist–induced foot tapping response for over 24 h. An appreciable amount of T-2328 was present in the brain 32 and 72 h after the injection. The NK1 agonist–induced contractions of isolated ileum in guinea pigs was antagonized with IC50 values of 1.4 nM in an insurmountable manner. It is likely that T-2328 exerts the long-lasting anti-emetic effect by not only long-term presence in the brain but also its insurmountable inhibition of NK1 receptors.
- 社団法人 日本薬理学会の論文
- 2008-06-20
著者
-
Watanabe Yumi
Pharmacology Laboratory Mitsubishi Tanabe Pharma Corporation
-
Taniguchi Hiroyuki
Pharmacology Laboratory Mitsubishi Tanabe Pharma Corporation
-
OKAMOTO Masahito
Sales & Marketing Division, Mitsubishi Tanabe Pharma Corporation
-
ISHII Taketoshi
Pharmacology Laboratory, Mitsubishi Tanabe Pharma Corporation
-
TAKATSUKA Satomi
DMPK Research Laboratory, Mitsubishi Tanabe Pharma Corporation
-
NAGASAKI Masaaki
Pharmacology Laboratory, Mitsubishi Tanabe Pharma Corporation
-
SAITO Akira
Research Strategy & Planning, Mitsubishi Tanabe Pharma Corporation
-
Taniguchi Hiroyuki
Pharmacological Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Ishii Taketoshi
Pharmacology Laboratory Mitsubishi Tanabe Pharma Corporation
-
Ishii Taketoshi
Pharmacology Department Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Nagasaki M
Pharmacology Laboratory Mitsubishi Tanabe Pharma Corporation
-
Okamoto Masahito
Sales & Marketing Division Mitsubishi Tanabe Pharma Corporation
-
Takatsuka Satomi
Dmpk Research Laboratory Mitsubishi Tanabe Pharma Corporation
-
Nagasaki Masaaki
Pharmacology Laboratory Mitsubishi Tanabe Pharma Corporation
-
Saito Akira
Research Strategy & Planning Mitsubishi Tanabe Pharma Corporation
-
Watanabe Yumi
Pharmacology Department, Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
Nagasaki Masaaki
Pharmacological Research Laboratory, Tanabe Seiyaku Co., Ltd.
関連論文
- Long-Lasting Anti-emetic Effect of T-2328, a Novel NK_1 Antagonist
- Pharmacological Characterization of T-2328, 2-Fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile Dihydrochloride, as a Brain-Penetrating Antagonist of Tachykinin NK_1 Receptor
- Effects of Cholecystokinin (CCK)-JMV-180 on the CCK Receptors of Rabbit Pancreatic Acini and Gallbladder Smooth Muscle
- Focal Cerebral Ischemia-Induced Escape Deficit in Rats Is Ameliorated by a Reversible Inhibitor of Monoamine Oxidase-A : Implications for a Novel Animal Model of Post-Stroke Depression
- Metabolic Abnormalities Caused by 3-Acetylpyridine in the Cerebral Motor Regions of Rats: Partial Recovery by Thyrotropin-Releasing Hormone
- A Novel Na^+ and Ca^ Channel Blocker, T-477, Prevents Brain Edema Following Microsphere-Induced Permanent Occlusion of Cerebral Arterioles in Rats
- Time-Dependent Changes in the Ischemic Forebrain Following the Microsphere-Induced Permanent Occlusion of Cerebral Arterioles in Rats
- Anti-apoptotic Effect of Acetyl-l-carnitine and l-Carnitine in Primary Cultured Neurons
- Pharmacological Characterization of T-2328, 2-Fluoro-4-methoxy-3-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1-biphenyl]-4-carbonitrile Dihydrochloride, as a Brain-Penetrating Antagonist of Tachykinin NK1 Receptor
- Effect of Trimebutine on Contractile Responses in Skinned Ileal Smooth Muscle.